No Data
No Data
Earnings Preview: SGMO to Report Financial Results Post-market on November 12
H.C. Wainwright Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating, Raises Target Price to $10
Express News | Sangamo Therapeutics Inc : H.c. Wainwright Raises Target Price to $10 From $5
Sangamo Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
Individual Investors Who Own 55% Along With Institutions Invested in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Saw Increase in Their Holdings Value Last Week
Booz Allen Posts Upbeat Q3 Earnings, Joins Deckers Outdoor, Saia, Boyd Gaming And Other Big Stocks Moving Higher On Friday
No Data
No Data
74910385 : Big AL are you still holding $Sangamo Therapeutics (SGMO.US)$
BigAlMoney OP 74910385 : Yes still holding probably for awhile SGMO. Waiting for Faby deal announcement. Hopefully before earnings next Tuesday. Hopefully good up front $$